Active Ingredient History
Colony-stimulating factors (CSFs) are secreted glycoproteins that bind to receptor proteins on the surfaces of committed progenitors in the bone marrow, thereby activating intracellular signaling pathways that can cause the cells to proliferate and differentiate into a specific kind of blood cell. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abnormalities, Radiation-Induced (approved 2015)
Neutropenia (approved 1991)
Abortion, Habitual (Phase 4)
Acne Vulgaris (Phase 2)
Acute-On-Chronic Liver Failure (Phase 3)
Adenocarcinoma (Phase 1)
Adenocarcinoma of Lung (Phase 1)
Adrenal Gland Neoplasms (Phase 3)
Adrenocortical Carcinoma (Phase 3)
Agammaglobulinemia (Phase 3)
Allergy and Immunology (Phase 1/Phase 2)
Allogeneic Cells (Phase 2)
Allografts (Phase 2)
Alzheimer Disease (Phase 2)
Amyloidosis (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Anemia (Phase 4)
Anemia, Aplastic (Phase 3)
Anemia, Diamond-Blackfan (Phase 2/Phase 3)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Refractory (Phase 3)
Anemia, Sickle Cell (Phase 2/Phase 3)
Anterior Wall Myocardial Infarction (Phase 3)
Antigens, CD19 (Phase 1/Phase 2)
Appendicitis (Phase 2)
Arthritis, Rheumatoid (Phase 1)
Astrocytoma (Phase 1)
Autografts (Early Phase 1)
Autoimmune Diseases (Phase 2/Phase 3)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Blood (Phase 1)
Bone Marrow Cells (Phase 2)
Bone Marrow Diseases (Phase 1)
Bone Marrow Failure Disorders (Phase 2)
Bone Marrow Transplantation (Phase 2)
Bortezomib (Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 4)
Breast Neoplasms, Male (Phase 2)
Brenner Tumor (Phase 2)
Burkitt Lymphoma (Phase 4)
Burns (Phase 4)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 1)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Merkel Cell (Phase 1)
Carcinoma, Mucoepidermoid (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 1)
Carcinoma, Verrucous (Phase 1)
Cardiomyopathy, Dilated (Phase 2)
Cardiotoxicity (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Cerebral Palsy (Phase 2)
Cerebrospinal Fluid (Phase 1)
Chagas Cardiomyopathy (Phase 3)
Chordoma (Phase 1)
Choriocarcinoma (Phase 3)
Choroid Plexus Neoplasms (Phase 3)
Chronic Limb-Threatening Ischemia (Phase 4)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Conjunctival Neoplasms (Phase 1)
COVID-19 (Phase 4)
Craniopharyngioma (Phase 1)
Critical Illness (Phase 2/Phase 3)
Crohn Disease (Phase 3)
Cyclophosphamide (Phase 3)
Cytokines (Phase 2)
Cytomegalovirus Retinitis (Phase 3)
Deficiency Diseases (Phase 1)
Dexamethasone (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Foot (Phase 1/Phase 2)
Diarrhea (Phase 2)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Digestive System Neoplasms (Phase 1)
DNA Mismatch Repair (Phase 1)
Down Syndrome (Phase 2)
Doxorubicin (Phase 3)
Drugs, Investigational (Phase 2)
Drug Therapy (Phase 2/Phase 3)
Dyskeratosis Congenita (Phase 2)
Electroconvulsive Therapy (Phase 2)
Embryo Implantation (Phase 3)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
End Stage Liver Disease (Phase 1)
Enterocolitis, Necrotizing (Phase 1/Phase 2)
Ependymoma (Phase 1)
Epidermolysis Bullosa Dystrophica (Phase 2)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Febrile Neutropenia (Phase 3)
Feeding and Eating Disorders (Phase 1/Phase 2)
Felty Syndrome (Phase 2)
Fertilization in Vitro (Phase 3)
Fever (Phase 3)
Fibrosis (Phase 3)
Frailty (Phase 1/Phase 2)
Gallbladder Neoplasms (Phase 2)
Ganglioneuroblastoma (Phase 2)
Gastrointestinal Stromal Tumors (Phase 1)
Geriatrics (Phase 3)
Germinoma (Phase 3)
Gestational Trophoblastic Disease (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 2)
Gliosarcoma (Phase 3)
Graft vs Host Disease (Phase 4)
Granulocyte Colony-Stimulating Factor (Phase 2/Phase 3)
Granuloma (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 3)
Heart Failure (Phase 2/Phase 3)
Hematologic Diseases (Phase 3)
Hematologic Neoplasms (Phase 4)
Hematology (Phase 2)
Hematopoietic Stem Cells (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2/Phase 3)
Hemoglobinopathies (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hemorrhagic Stroke (Phase 1/Phase 2)
Hepacivirus (Phase 4)
Hepatitis, Alcoholic (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatoblastoma (Phase 4)
Herpesvirus 8, Human (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV (Phase 4)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 3)
Hypertension, Pulmonary (Phase 2)
Hypertrophy, Left Ventricular (Phase 3)
Immune System Diseases (Early Phase 1)
Immunoglobulin Light-chain Amyloidosis (Phase 3)
Infant, Premature (Phase 3)
Infections (Phase 3)
Infertility (Phase 4)
Infertility, Female (Phase 1/Phase 2)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Ischemic Stroke (Phase 2)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 3)
Kidney Transplantation (Phase 2)
Leg Ulcer (Phase 2)
Leiomyosarcoma (Phase 3)
Leishmaniasis, Cutaneous (Phase 3)
Leukemia (Phase 4)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 3)
Leukemia, Megakaryoblastic, Acute (Phase 1/Phase 2)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, Plasma Cell (Phase 1/Phase 2)
Leukemia, Prolymphocytic (Phase 1/Phase 2)
Leukocytes, Mononuclear (Phase 1/Phase 2)
Liver Cirrhosis (Phase 1)
Liver Diseases, Alcoholic (Phase 4)
Liver Failure (Phase 4)
Liver Neoplasms (Phase 2)
Living Donors (Phase 1)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 2)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Lymph Nodes (Phase 3)
Lymphocytosis (Phase 1)
Lymphoma (Phase 4)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 2/Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, Primary Cutaneous Anaplastic Large Cell (Early Phase 1)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 3)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Mediastinal Neoplasms (Phase 4)
Medulloblastoma (Phase 3)
Melanoma (Phase 4)
Meningioma (Phase 1)
Mesothelioma (Phase 2)
Mesothelioma, Malignant (Phase 2)
Multiple Myeloma (Phase 4)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Muscular Dystrophies (Phase 1)
Myasthenia Gravis (Early Phase 1)
Mycoses (Phase 4)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 4)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neonatal Sepsis (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2/Phase 3)
Neoplasms (Phase 4)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 4)
Neurodegenerative Diseases (Phase 1/Phase 2)
Neuroectodermal Tumors (Phase 3)
Neurofibromatosis 1 (Phase 2)
Neurofibrosarcoma (Phase 1)
Neutropenia (Phase 4)
Oligodendroglioma (Phase 1)
Organ Transplantation (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 3)
Pain (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma, Inverted (Phase 1)
Parkinson Disease (Phase 2)
Pediatrics (Phase 1)
Pemphigus (Phase 2)
Periodontitis (Phase 1)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Early Phase 1)
Pharmacokinetics (Phase 1)
Pheochromocytoma (Phase 3)
Physiological Effects of Drugs (Phase 1)
Pneumonia (Phase 1)
Pouchitis (Phase 1/Phase 2)
Precancerous Conditions (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 3)
Primary Ovarian Insufficiency (Phase 4)
Prognosis (Phase 2)
Prostatic Neoplasms (Phase 4)
Prostatic Neoplasms, Castration-Resistant (Phase 2/Phase 3)
Prostheses and Implants (Phase 3)
Pulmonary Alveolar Proteinosis (Phase 2/Phase 3)
Purpura, Thrombocytopenic (Phase 2)
Radiation Oncology (Phase 2)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Tract Infections (Phase 1)
Retinal Neoplasms (Phase 3)
Retinoblastoma (Phase 4)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 3)
Salivary Gland Neoplasms (Phase 1)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sarcoma, Myeloid (Phase 2)
Sarcoma, Synovial (Phase 1)
SARS-CoV-2 (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2/Phase 3)
Sclerosis (Phase 2/Phase 3)
Seminoma (Phase 3)
Sepsis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shock, Septic (Phase 3)
Shwachman-Diamond Syndrome (Phase 2/Phase 3)
Sickle Cell Trait (Phase 3)
Skin Neoplasms (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 1/Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stem Cell Transplantation (Phase 2)
Stevens-Johnson Syndrome (Phase 4)
Stomach Neoplasms (Phase 2)
Stroke (Phase 2)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 3)
Thalassemia (Phase 2/Phase 3)
Therapeutics (Phase 2)
Thrombocytopenia (Phase 2)
Thymoma (Phase 2)
Thyroid Neoplasms (Phase 1)
Translocation, Genetic (Phase 2)
Transplantation (Phase 1)
Transplantation, Autologous (Phase 2)
Transplantation, Homologous (Phase 2)
Traumatology (Phase 4)
Triple Negative Breast Neoplasms (Phase 1)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urological Manifestations (Phase 1/Phase 2)
Uterine Cervical Neoplasms (Phase 4)
Uterine Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Warts (Phase 3)
Wilms Tumor (Phase 3)
Wiskott-Aldrich Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
